Literature DB >> 15140079

CTAB-urea method purifies RNA from melanin for cDNA microarray analysis.

M Stefania Lagonigro1, Loris De Cecco, Piero Carninci, Delia Di Stasi, Tiziana Ranzani, Monica Rodolfo, Manuela Gariboldi.   

Abstract

Melanin represents a major problem for the study of melanoma by microarrays since it is retained during RNA extraction and inhibits the enzymatic reactions used for probe preparation. Here we report a new method for cleaning RNA from melanin, based on the use of the cationic detergent cetyl-trimethylammonium bromide (CTAB)-urea for RNA precipitation. This method is easy to perform and has a low cost. Purified RNA is recovered with high quality and good yield. CTAB-urea treated RNA from highly pigmented melanoma cells can be successfully reverse transcribed and labeled to obtain probes which can be subsequently used in cDNA microarray experiments, giving consistent and reproducible results.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15140079     DOI: 10.1111/j.1600-0749.2004.00155.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  8 in total

1.  Extraction of high-quality, melanin-free RNA From Mycosphaerella fijiensis for cDNA preparation.

Authors:  Ignacio Islas-Flores; Leticia Peraza-Echeverría; Blondy Canto-Canché; Cecilia Mónica Rodríguez-García
Journal:  Mol Biotechnol       Date:  2006-09       Impact factor: 2.695

2.  Tiny RNAs associated with transcription start sites in animals.

Authors:  Ryan J Taft; Evgeny A Glazov; Nicole Cloonan; Cas Simons; Stuart Stephen; Geoffrey J Faulkner; Timo Lassmann; Alistair R R Forrest; Sean M Grimmond; Kate Schroder; Katharine Irvine; Takahiro Arakawa; Mari Nakamura; Atsutaka Kubosaki; Kengo Hayashida; Chika Kawazu; Mitsuyoshi Murata; Hiromi Nishiyori; Shiro Fukuda; Jun Kawai; Carsten O Daub; David A Hume; Harukazu Suzuki; Valerio Orlando; Piero Carninci; Yoshihide Hayashizaki; John S Mattick
Journal:  Nat Genet       Date:  2009-04-19       Impact factor: 38.330

3.  Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction.

Authors:  Daniel K Wells; Marit M van Buuren; Kristen K Dang; Vanessa M Hubbard-Lucey; Kathleen C F Sheehan; Katie M Campbell; Andrew Lamb; Jeffrey P Ward; John Sidney; Ana B Blazquez; Andrew J Rech; Jesse M Zaretsky; Begonya Comin-Anduix; Alphonsus H C Ng; William Chour; Thomas V Yu; Hira Rizvi; Jia M Chen; Patrice Manning; Gabriela M Steiner; Xengie C Doan; Taha Merghoub; Justin Guinney; Adam Kolom; Cheryl Selinsky; Antoni Ribas; Matthew D Hellmann; Nir Hacohen; Alessandro Sette; James R Heath; Nina Bhardwaj; Fred Ramsdell; Robert D Schreiber; Ton N Schumacher; Pia Kvistborg; Nadine A Defranoux
Journal:  Cell       Date:  2020-10-09       Impact factor: 41.582

4.  Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis.

Authors:  Maximilian O Schaettler; Megan M Richters; Malachi Griffith; Gavin P Dunn; Anthony Z Wang; Zachary L Skidmore; Bryan Fisk; Katherine E Miller; Tammi L Vickery; Albert H Kim; Michael R Chicoine; Joshua W Osbun; Eric C Leuthardt; Joshua L Dowling; Gregory J Zipfel; Ralph G Dacey; Hsiang-Chih Lu; Tanner M Johanns; Obi L Griffith; Elaine R Mardis
Journal:  Cancer Discov       Date:  2021-10-05       Impact factor: 38.272

5.  A melanin-bleaching methodology for molecular and histopathological analysis of formalin-fixed paraffin-embedded tissue.

Authors:  Joon-Yong Chung; Jiyeon Choi; John D Sears; Kris Ylaya; Candice Perry; Chel H Choi; Seung-Mo Hong; Hanbyoul Cho; Kevin M Brown; Stephen M Hewitt
Journal:  Lab Invest       Date:  2016-08-22       Impact factor: 5.662

6.  Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma.

Authors:  Einar Birkeland; Christian Busch; Elisabet Ognedal Berge; Jürgen Geisler; Göran Jönsson; Johan Richard Lillehaug; Stian Knappskog; Per Eystein Lønning
Journal:  Clin Exp Metastasis       Date:  2013-05-15       Impact factor: 5.150

7.  SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling.

Authors:  Thomas Strub; Flavia G Ghiraldini; Saul Carcamo; Man Li; Aleksandra Wroblewska; Rajendra Singh; Matthew S Goldberg; Dan Hasson; Zichen Wang; Stuart J Gallagher; Peter Hersey; Avi Ma'ayan; Georgina V Long; Richard A Scolyer; Brian Brown; Bin Zheng; Emily Bernstein
Journal:  Nat Commun       Date:  2018-08-24       Impact factor: 14.919

8.  Massively parallel reporter assays of melanoma risk variants identify MX2 as a gene promoting melanoma.

Authors:  Jiyeon Choi; Tongwu Zhang; Andrew Vu; Julien Ablain; Matthew M Makowski; Leandro M Colli; Mai Xu; Rebecca C Hennessey; Jinhu Yin; Harriet Rothschild; Cathrin Gräwe; Michael A Kovacs; Karen M Funderburk; Myriam Brossard; John Taylor; Bogdan Pasaniuc; Raj Chari; Stephen J Chanock; Clive J Hoggart; Florence Demenais; Jennifer H Barrett; Matthew H Law; Mark M Iles; Kai Yu; Michiel Vermeulen; Leonard I Zon; Kevin M Brown
Journal:  Nat Commun       Date:  2020-06-01       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.